Citigroup’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.18M | Sell |
220,000
-1,033,400
| -82% | -$27.5M | ﹤0.01% | 1802 |
|
|
2025
Q4 | $31.2M | Buy |
1,253,400
+778,400
| +164% | +$19.6M | 0.01% | 862 |
|
|
2025
Q3 | $12.1M | Sell |
475,000
-645,100
| -58% | -$15.9M | 0.01% | 1367 |
|
|
2025
Q2 | $27.2M | Sell |
1,120,100
-314,500
| -22% | -$7.33M | 0.01% | 823 |
|
|
2025
Q1 | $36.4M | Buy |
1,434,600
+381,400
| +36% | +$9.98M | 0.02% | 694 |
|
|
2024
Q4 | $27.9M | Sell |
1,053,200
-501,300
| -32% | -$13.6M | 0.02% | 780 |
|
|
2024
Q3 | $45M | Buy |
1,554,500
+752,600
| +94% | +$22M | 0.03% | 578 |
|
|
2024
Q2 | $22.4M | Buy |
801,900
+259,100
| +48% | +$7.13M | 0.01% | 831 |
|
|
2024
Q1 | $15.1M | Sell |
542,800
-75,500
| -12% | -$2.1M | 0.01% | 1029 |
|
|
2023
Q4 | $17.8M | Buy |
618,300
+67,800
| +12% | +$2.05M | 0.01% | 914 |
|
|
2023
Q3 | $18.3M | Buy |
550,500
+158,200
| +40% | +$5.59M | 0.01% | 807 |
|
|
2023
Q2 | $14.4M | Sell |
392,300
-291,000
| -43% | -$11.3M | 0.01% | 969 |
|
|
2023
Q1 | $27.9M | Sell |
683,300
-1,049,900
| -61% | -$45.3M | 0.02% | 647 |
|
|
2022
Q4 | $88.8M | Buy |
1,733,200
+1,042,100
| +151% | +$50M | 0.07% | 253 |
|
|
2022
Q3 | $30.2M | Buy |
691,100
+81,500
| +13% | +$3.96M | 0.02% | 578 |
|
|
2022
Q2 | $32M | Sell |
609,600
-514,400
| -46% | -$26.2M | 0.02% | 573 |
|
|
2022
Q1 | $58.2M | Sell |
1,124,000
-1,747,800
| -61% | -$90.7M | 0.04% | 444 |
|
|
2021
Q4 | $170M | Buy |
2,871,800
+871,100
| +44% | +$43.2M | 0.09% | 199 |
|
|
2021
Q3 | $86M | Buy |
2,000,700
+235,600
| +13% | +$10.4M | 0.05% | 332 |
|
|
2021
Q2 | $69.1M | Buy |
1,765,100
+253,400
| +17% | +$9.85M | 0.04% | 414 |
|
|
2021
Q1 | $54.8M | Sell |
1,511,700
-1,794,300
| -54% | -$63.7M | 0.04% | 464 |
|
|
2020
Q4 | $122M | Buy |
3,306,000
+1,501,552
| +83% | +$55.1M | 0.07% | 247 |
|
|
2020
Q3 | $62.8M | Buy |
1,804,448
+624,390
| +53% | +$21.9M | 0.04% | 370 |
|
|
2020
Q2 | $36.6M | Sell |
1,180,058
-431,192
| -27% | -$14.6M | 0.03% | 515 |
|
|
2020
Q1 | $49.9M | Buy |
1,611,250
+246,425
| +18% | +$8.4M | 0.05% | 357 |
|
|
2019
Q4 | $50.7M | Sell |
1,364,825
-304,395
| -18% | -$10.8M | 0.04% | 504 |
|
|
2019
Q3 | $56.9M | Buy |
1,669,220
+826,969
| +98% | +$30.1M | 0.05% | 399 |
|
|
2019
Q2 | $34.6M | Sell |
842,251
-1,084,145
| -56% | -$43M | 0.03% | 612 |
|
|
2019
Q1 | $77.6M | Sell |
1,926,396
-152,514
| -7% | -$6.11M | 0.07% | 245 |
|
|
2018
Q4 | $86.1M | Buy |
2,078,910
+6,535
| +0.3% | +$271K | 0.09% | 221 |
|
|
2018
Q3 | $86.7M | Buy |
2,072,375
+159,787
| +8% | +$6.15M | 0.08% | 226 |
|
|
2018
Q2 | $65.8M | Buy |
1,912,588
+253,592
| +15% | +$8.67M | 0.06% | 270 |
|
|
2018
Q1 | $55.9M | Sell |
1,658,996
-16,232
| -1% | -$558K | 0.05% | 351 |
|
|
2017
Q4 | $57.6M | Sell |
1,675,228
-867,336
| -34% | -$29.6M | 0.05% | 384 |
|
|
2017
Q3 | $86.1M | Buy |
2,542,564
+1,358,922
| +115% | +$43.7M | 0.07% | 233 |
|
|
2017
Q2 | $37.7M | Sell |
1,183,642
-280,891
| -19% | -$8.86M | 0.03% | 462 |
|
|
2017
Q1 | $47.5M | Sell |
1,464,533
-3,170,432
| -68% | -$100M | 0.04% | 378 |
|
|
2016
Q4 | $143M | Buy |
4,634,965
+1,814,145
| +64% | +$55.4M | 0.13% | 127 |
|
|
2016
Q3 | $90.6M | Sell |
2,820,820
-305,555
| -10% | -$10.2M | 0.08% | 210 |
|
|
2016
Q2 | $104M | Sell |
3,126,375
-120,156
| -4% | -$3.83M | 0.11% | 169 |
|
|
2016
Q1 | $91.3M | Sell |
3,246,531
-4,186,488
| -56% | -$120M | 0.1% | 173 |
|
|
2015
Q4 | $228M | Sell |
7,433,019
-1,056,002
| -12% | -$33.2M | 0.23% | 62 |
|
|
2015
Q3 | $253M | Buy |
8,489,021
+5,301,409
| +166% | +$170M | 0.24% | 50 |
|
|
2015
Q2 | $101M | Sell |
3,187,612
-9,812,846
| -75% | -$320M | 0.09% | 198 |
|
|
2015
Q1 | $429M | Buy |
13,000,458
+3,235,780
| +33% | +$103M | 0.41% | 24 |
|
|
2014
Q4 | $289M | Buy |
9,764,678
+1,788,744
| +22% | +$51.3M | 0.26% | 43 |
|
|
2014
Q3 | $224M | Buy |
7,975,934
+2,491,972
| +45% | +$69.9M | 0.2% | 67 |
|
|
2014
Q2 | $154M | Buy |
5,483,962
+3,291,958
| +150% | +$93.8M | 0.15% | 110 |
|
|
2014
Q1 | $66.8M | Buy |
2,192,004
+244,634
| +13% | +$7.29M | 0.07% | 245 |
|
|
2013
Q4 | $56.6M | Sell |
1,947,370
-2,197,696
| -53% | -$64M | 0.05% | 335 |
|
|
2013
Q3 | $113M | Sell |
4,145,066
-269,929
| -6% | -$7.34M | 0.11% | 155 |
|
|
2013
Q2 | $117M | Buy |
+4,414,995
| New | +$122M | 0.12% | 123 |
|
Other funds holding PFE
VCM
VPM
Citigroup's PFE Position: Q1 2026 in Review
Citigroup increased its Pfizer (PFE) stake by 8.6% in Q1 2026, buying an estimated $32.7M and bringing the position to 15,493,259 shares worth $435M. The position accounts for 0.19% of the portfolio, ranked #98.
Citigroup first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Citigroup held 15,493,259 shares of Pfizer worth $435M as of Q1 2026.
- Citigroup bought 1,228,140 Pfizer shares in Q1 2026, an estimated $32.7M.
- Pfizer made up 0.19% of Citigroup's portfolio in Q1 2026, its #98 holding.
- Citigroup first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.